Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Fracanzani, Anna Ludovica ^a   Valenti, Luca ^a   Russello, Maurizio ^b   Miele, Luca ^c   Bertelli, Cristina ^a   Bellia, Alessandro ^b   Masetti, Chiara ^a   Cefalo, Consuelo ^c   Grieco, Antonio ^c   Marchesini, Giulio ^d   Fargion, Silvia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CHOLELITHIASIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREVALENCE;

ADULT; AGE FACTORS; AGED; ANIMALS; DIABETES COMPLICATIONS; FATTY LIVER; FEMALE; GALLSTONES; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84864652073     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041183     Document Type: Article

References (38)

1. Angulo P, (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
2. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, et al. (2002) Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134-140.
3. Vernon G, Baranova A, Younossi ZM, (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34: 274-285.
4. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK, (2009) NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 104: 861-867.
5. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.
6. Younossi ZM, (2008) Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 28: 2-12.
7. Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, et al. (2008) Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 121: 72-78.
8. Targher G, Day CP, Bonora E, (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363: 1341-1350.
9. Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, et al. (2010) Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis 211: 182-186.
10. Everhart JE, Khare M, Hill M, Maurer KR, (1999) Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 117: 632-639.
11. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, et al. (1995) Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol 141: 158-165.
12. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, et al. (1997) Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 25: 787-790.
13. Diehl AK, (2000) Cholelithiasis and the insulin resistance syndrome. Hepatology 31: 528-530.
14. Ruhl CE, Everhart JE, (2000) Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 31: 299-303.
15. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL, (2008) Macronutrients and insulin resistance in cholesterol gallstone disease. Am J Gastroenterol 103: 2932-2939.
16. Xie Y, Newberry EP, Kennedy SM, Luo J, Davidson NO, (2009) Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J Lipid Res 50: 977-987.
17. Chang Y, Sung E, Ryu S, Park YW, Jang YM, et al. (2008) Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci 23: 644-650.
18. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, et al. (2008) Risk of severe liver disease in NAFLD with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology 48: 792-798.
19. Fracanzani AL, Valenti L, Bugianesi E, Vanni E, Grieco A, et al. (2011) Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol 54: 1244-1249.
20. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
21. Brunt EM, (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16.
22. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 28: 412-419.
24. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, et al. (2005) Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 20: 1176-1184.
25. Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB, Perez-Morales AG, Martinez S, et al. (2008) Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 12: 2097-2102; discussion 2102.
26. Olokoba AB, Bojuwoye BJ, Olokoba LB, Braimoh KT, Inikori AK, (2007) Gallstone disease and type-2 diabetes mellitus-the link. J Coll Physicians Surg Pak 17: 594-597.
27. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL, (2006) Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 55: 708-714.
28. Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, et al. (2008) Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity. Obes Surg 18: 847-853.
29. Shaffer EA, (2006) Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20: 981-996.
30. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, et al. (2005) Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 11: 1653-1657.
31. Bodmer M, Brauchli YB, Jick SS, Meier CR, (2011) Diabetes mellitus and the risk of cholecystectomy. Dig Liver Dis 43: 742-747.
32. Noel RA, Braun DK, Patterson RE, Bloomgren GL, (2009) Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care 32: 834-838.
33. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL, (2009) Statin use and the risk of cholecystectomy in women. Gastroenterology 136: 1593-1600.
34. Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, et al. (2008) Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 14: 778-782.
35. Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, et al. (2011) The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 54: 1208-1216.
36. Ioannou GN, (2010) Cholelithiasis, cholecystectomy, and liver disease. Am J Gastroenterol 105: 1364-1373.
37. Padda MS, Singh S, Tang SJ, Rockey DC, (2009) Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis. Aliment Pharmacol Ther 29: 1011-1018.
38. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G, (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53: 372-384.